Penthrop Inhalation 5 ml Inhalation
PDF Leaflet Revision Date: 5 October 2021
Clinical Summary
Quick overview from the medicine insert
Indication
Emergency relief of pain in conscious patients.
Dosage (summary)
Adults: Up to 6 ml/day; max 15 ml/week. Children: 1-11 years: Up to 3 ml/day; 12-17 years: Up to 6 ml/day.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Caution in pregnancy; potential CNS and respiratory depression in newborns. Use with caution in breastfeeding.
Key Drug Interactions
- Enzyme inducers
- CNS depressants
- Tetracycline
Contraindications
- Hypersensitivity to methoxyflurane
- Renal impairment
- Severe hepatic impairment
- Cardiovascular instability
- Respiratory depression
Common side effects
- Dizziness
- Headache
- Nausea
- Somnolence
Counselling Points
- Use lowest effective dose
- Monitor cumulative dose
- Avoid driving until fully recovered
Serious warnings
- Nephrotoxicity
- Potential for abuse
- CNS effects
Important Disclaimer
The Penthrop Inhalation 5 ml Inhalation professional information leaflet below is the property of Equity Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
